BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9751928)

  • 1. Dynamic distribution and dosimetric evaluation of human non-specific immunoglobulin G labelled with 111In or 99Tcm.
    Buijs WC; Oyen WJ; Dams ET; Boerman OC; Siegel JA; Claessens RA; van der Meer JW; Corstens FH
    Nucl Med Commun; 1998 Aug; 19(8):743-51. PubMed ID: 9751928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous administration of 99Tcm-HMPAO-labelled autologous leukocytes and 111In-labelled non-specific polyclonal human immunoglobulin G in bone and joint infections.
    de Lima Ramos PA; Martin-Comin J; Bajén MT; Roca M; Ricart Y; Castell M; Mora J; Puchal R; Ramos M
    Nucl Med Commun; 1996 Sep; 17(9):749-57. PubMed ID: 8895902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
    Kemerink GJ; Liu X; Kieffer D; Ceyssens S; Mortelmans L; Verbruggen AM; Steinmetz ND; Vanderheyden JL; Green AM; Verbeke K
    J Nucl Med; 2003 Jun; 44(6):947-52. PubMed ID: 12791824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient dosimetry of intravenously administered 99mTc-annexin V.
    Kemerink GJ; Liem IH; Hofstra L; Boersma HH; Buijs WC; Reutelingsperger CP; Heidendal GA
    J Nucl Med; 2001 Feb; 42(2):382-7. PubMed ID: 11216539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-tracer dosimetry of organs in assessment of bone marrow involvement by two monoclonal antibodies.
    Korppi-Tommola ET; Kairemo KJ; Jekunen AP; Niskanen EO; Savolainen SE
    Acta Oncol; 1996; 35(3):357-65. PubMed ID: 8679267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution and dosimetry of indium-111-polyclonal IgG in normal subjects.
    Datz FL; Castronovo FP; Christian PE; Anderson CE; Crebs K; Morton KA; Rauh DA
    J Nucl Med; 1995 Dec; 36(12):2372-9. PubMed ID: 8523134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.
    Virgolini I; Szilvasi I; Kurtaran A; Angelberger P; Raderer M; Havlik E; Vorbeck F; Bischof C; Leimer M; Dorner G; Kletter K; Niederle B; Scheithauer W; Smith-Jones P
    J Nucl Med; 1998 Nov; 39(11):1928-36. PubMed ID: 9829585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution and dosimetry of technetium-99m-hydrazino nicotinamide IgG: comparison with indium-111-DTPA-IgG.
    Callahan RJ; Barrow SA; Abrams MJ; Rubin RH; Fischman AJ
    J Nucl Med; 1996 May; 37(5):843-6. PubMed ID: 8965158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution and dosimetry of 99mTc-BTAP-annexin-V in humans.
    Kemerink GJ; Boersma HH; Thimister PW; Hofstra L; Liem IH; Pakbiers MT; Janssen D; Reutelingsperger CP; Heidendal GA
    Eur J Nucl Med; 2001 Sep; 28(9):1373-8. PubMed ID: 11585297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phase I clinical study for 111In-DTPA-IgG].
    Kubo A; Nakamura K; Hashimoto J; Hashimoto T; Sammiya T; Shimizu S; Shimada K
    Kaku Igaku; 1994 Sep; 31(9):1121-31. PubMed ID: 7967198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution, radiation dosimetry and pharmacokinetics of 111In-antimyosin in idiopathic inflammatory myopathies.
    Smith T; Senior R; Raval U; Dasgupta B; Lahiri A
    J Nucl Med; 1999 Mar; 40(3):464-70. PubMed ID: 10086712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric evaluation of immunoscintigraphy using indium-111-labeled monoclonal antibody fragments in patients with ovarian cancer.
    Buijs WC; Massuger LF; Claessens RA; Kenemans P; Corstens FH
    J Nucl Med; 1992 Jun; 33(6):1113-20. PubMed ID: 1597725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patients.
    Cremonesi M; Ferrari M; Chinol M; Stabin MG; Grana C; Prisco G; Robertson C; Tosi G; Paganelli G
    Eur J Nucl Med; 1999 Feb; 26(2):110-20. PubMed ID: 9933344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of radiolabeled chemotactic peptide at focal sites of Escherichia coli infection in rabbits: evidence for a receptor-specific mechanism.
    Babich JW; Tompkins RG; Graham W; Barrow SA; Fischman AJ
    J Nucl Med; 1997 Aug; 38(8):1316-22. PubMed ID: 9255175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation dosimetry of a 99mTc-labeled IgM murine antibody to CD15 antigens on human granulocytes.
    Mozley PD; Stubbs JB; Dresel SH; Barraclough ED; Smith T; Patel M; Finkelman C; Sparks RB; Thakur ML; Mathur A; Alavi A
    J Nucl Med; 1999 Apr; 40(4):625-30. PubMed ID: 10210221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters.
    Booij J; Busemann Sokole E; Stabin MG; Janssen AG; de Bruin K; van Royen EA
    Eur J Nucl Med; 1998 Jan; 25(1):24-30. PubMed ID: 9396871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indium-111-labelled liposomes: dosimetry and tumour detection in patients with cancer.
    Kubo A; Nakamura K; Sammiya T; Katayama M; Hashimoto T; Hashimoto S; Kobayashi H; Teramoto T
    Eur J Nucl Med; 1993 Feb; 20(2):107-13. PubMed ID: 8440266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiolabeling, biodistribution, and dosimetry of (123)I-mAb 14C5: a new mAb for radioimmunodetection of tumor growth and metastasis in vivo.
    Lahorte CM; Bacher K; Burvenich I; Coene ED; Cuvelier C; De Potter C; Thierens H; Van de Wiele C; Dierckx RA; Slegers G
    J Nucl Med; 2004 Jun; 45(6):1065-73. PubMed ID: 15181142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison between 111In-anti-E-selectin mAb and 99Tcm-labelled human non-specific immunoglobulin in radionuclide imaging of rheumatoid arthritis.
    Jamar F; Chapman PT; Manicourt DH; Glass DM; Haskard DO; Peters AM
    Br J Radiol; 1997 May; 70(833):473-81. PubMed ID: 9227228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99m labeled to human immunoglobulin G through the nicotinyl hydrazine derivative: a clinical study.
    Dams ET; Oyen WJ; Boerman OC; Claessens RA; Wymenga AB; van der Meer JW; Corstens FH
    J Nucl Med; 1998 Jan; 39(1):119-24. PubMed ID: 9443750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.